Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.
Malard F, Bobin A, Labopin M, Karlin L, Frenzel L, Roussel M, Vignon M, Godet S, Chalopin T, Moyer P, Chalayer E, Orsini Piocelle F, Mariette C, Croizier C, Sohn C, Dib M, Le Calloch R, Ali-Ammar N, Loirat M, Benbrahim O, Payssot A, Trebouet A, Perrot A, Leleu X, Mohty M.
Malard F, et al. Among authors: vignon m.
Blood Cancer J. 2024 Dec 18;14(1):219. doi: 10.1038/s41408-024-01200-w.
Blood Cancer J. 2024.
PMID: 39695076
Free PMC article.
No abstract available.